Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eli Lilly And Co Raises FY 2013 EPS Guidance; Reaffirms FY 2013 Revenue Guidance


Wednesday, 24 Jul 2013 06:30am EDT 

Eli Lilly And Co raised its fiscal 2013 earnings per share guidance and now expects fiscal 2013 earnings per share to be in the range of $4.28 to $4.38 on a reported basis, or $4.05 to $4.15 on a non-GAAP basis. The Company still anticipates fiscal 2013 revenue of between $22.6 billion and $23.4 billion. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.92 and revenue of $22.8 billion for fiscal 2013. 

Company Quote

45.988
0.183 +0.40%
11 Jul 2014